Tandem Diabetes Care [TNDM] vs Stryker [SYK] Detailed Stock Comparison

Tandem Diabetes Care Inc.

NASDAQ
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Tandem Diabetes Care Inc. wins in 3 metrics, Stryker Corporation wins in 17 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Tandem Diabetes Care Inc. Stryker Corporation Better
P/E Ratio (TTM) -6.80 39.21 Stryker Corporation
Price-to-Book Ratio 8.82 5.62 Stryker Corporation
Debt-to-Equity Ratio 289.60 72.97 Stryker Corporation
PEG Ratio 0.03 0.72 Tandem Diabetes Care Inc.
EV/EBITDA -25.23 19.90 Stryker Corporation
Profit Margin (TTM) -20.17% 12.92% Stryker Corporation
Operating Margin (TTM) 2.86% 27.24% Stryker Corporation
EBITDA Margin (TTM) 2.86% 27.24% Stryker Corporation
Return on Equity -97.89% 15.08% Stryker Corporation
Return on Assets (TTM) -5.28% 7.92% Stryker Corporation
Free Cash Flow (TTM) $-108.26M $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return -20.04% -17.25% Stryker Corporation
Price-to-Sales Ratio (TTM) 1.35 5.02 Tandem Diabetes Care Inc.
Enterprise Value $1.53B $138.30B Stryker Corporation
EV/Revenue Ratio 1.50 5.51 Tandem Diabetes Care Inc.
Gross Profit Margin (TTM) 57.67% 64.54% Stryker Corporation
Revenue per Share (TTM) $15 $66 Stryker Corporation
Earnings per Share (Diluted) $-3.04 $8.40 Stryker Corporation
Beta (Stock Volatility) 1.74 0.93 Stryker Corporation
Short % of Float 20.70% 1.20% Stryker Corporation

Tandem Diabetes Care Inc. vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

TNDM
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Tandem Diabetes Care Inc.0.96%-9.26%30.73%-23.51%-24.20%-22.23%
Stryker Corporation-1.36%2.13%0.38%-11.91%-13.33%-11.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Tandem Diabetes Care Inc.-20.04%-38.75%-82.30%-77.45%-92.40%-92.40%
Stryker Corporation-17.25%6.06%22.47%172.95%440.98%592.85%

Performance & Financial Health Analysis: Tandem Diabetes Care Inc. vs Stryker Corporation

MetricTNDMSYK
Market Information
Market Cap i$1.42B$126.25B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,506,2111,881,406
90 Day Avg. Volume i1,785,8942,161,139
Last Close$16.76$307.94
52 Week Range$9.98 - $29.65$281.00 - $404.87
% from 52W High-43.47%-23.94%
All-Time High$302.50 (Jan 13, 2014)$406.19 (Jan 27, 2025)
% from All-Time High-94.46%-24.19%
Growth Metrics
Quarterly Revenue Growth0.03%0.11%
Quarterly Earnings GrowthN/A0.56%
Financial Health
Profit Margin (TTM) i-0.20%0.13%
Operating Margin (TTM) i0.03%0.27%
Return on Equity (TTM) i-0.98%0.15%
Debt to Equity (MRQ) i289.6072.97
Cash & Liquidity
Book Value per Share (MRQ)$2.27$58.61
Cash per Share (MRQ)$4.28$10.71
Operating Cash Flow (TTM) i$-9,721,000$5.04B
Levered Free Cash Flow (TTM) i$-44,731,124$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A$3.40

Valuation & Enterprise Metrics Analysis: Tandem Diabetes Care Inc. vs Stryker Corporation

MetricTNDM (Apr 24, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-6.8039.21
Forward P/E i-848.0119.67
PEG Ratio i0.030.72
Price to Sales (TTM) i1.355.02
Price to Book (MRQ) i8.825.62
Market Capitalization
Market Capitalization i$1.42B$126.25B
Enterprise Value i$1.53B$138.30B
Enterprise Value Metrics
Enterprise to Revenue i1.505.51
Enterprise to EBITDA i-25.2319.90
Risk & Other Metrics
Beta i1.740.93
Book Value per Share (MRQ) i$2.27$58.61

Financial Statements Comparison: Tandem Diabetes Care Inc. vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTNDM (2025)SYK (2025)
Revenue/Sales i1.01B25.12B
Cost of Goods Sold i468.72M9.05B
COGS % of Revenue i46.2%36.0%
Gross Profit i546.01M16.07B
Gross Margin i53.8%64.0%
Research & Development i268.33M1.62B
Operating Income (EBIT) i-167.31M5.06B
Operating Margin i-16.5%20.1%
EBITDA i-156.61M6.48B
EBITDA Margin i-15.4%25.8%
Pre-Tax Income i-200.27M4.51B
Pre-Tax Income % of Revenue i-19.7%18.0%
Income Tax i4.44M1.27B
Income Tax % of Revenue i0.4%5.0%
Net Income (Profit) i-204.71M3.25B
Profit Margin i-20.2%12.9%

Balance Sheet & Liquidity Metrics

MetricTNDM (2025)SYK (2025)
Cash & Equivalents i90.63M4.01B
Total Current Assets i618.14M14.76B
Total Current Assets % of Revenue i60.9%58.7%
Total Current Liabilities i242.72M7.79B
Total Current Liabilities % of Revenue i23.9%31.0%
Long-Term Debt i425.00M14.86B
Long-Term Debt % of Revenue i41.9%59.2%
Total Shareholders Equity i155.17M22.42B
Retained Earnings i-1.25B20.47B
Retained Earnings % of Revenue i-123.4%81.5%
Property, Plant & Equipment i99.27M1.79B

Cash Flow Statement Comparison

MetricTNDM (2025)SYK (2025)
Operating Cash Flow i-19.81M4.70B
Operating Cash Flow % of Revenue i-2.0%18.7%
Capital Expenditures i-19.95M-761.00M
Free Cash Flow i-108.26M4.28B
FCF Margin i-10.7%17.1%
Debt Repayment i-40.76M-1.40B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTNDMSYK
Shares Short i10.53M4.42M
Short Ratio i5.381.95
Short % of Float i20.70%1.20%
Shares Outstanding i68.29M382.50M
Float Shares i62.60M346.55M
% Held by Insiders i0.75%5.37%
% Held by Institutions i110.78%82.09%
% Held by Public i-11.53%12.54%

Dividend Analysis & Yield Comparison: Tandem Diabetes Care Inc. vs Stryker Corporation

MetricTNDMSYK
Last 12-Month Dividend iN/A$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$9.69
Ex-Dividend DateN/ADec 31, 2025